pulmonologyadvisor2d
In COPD Treatment, Tezepelumab Not Linked to Reduced Exacerbations
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
Knowridge7d
First new treatment for asthma and COPD in half a century – new study
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
The Lancet10h
Chronic obstructive pulmonary disease: new therapies and old needs
Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...
Medscape3d
Nicotinamide Riboside Relieves Airway Inflammation in COPD
A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...
The Financial Express12d
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Hosted on MSN1mon
Asthma, COPD often not diagnosed, study indicates
They also obtained smoking cessation treatment, exercise and weight counseling, and pneumonia and flu vaccines, if appropriate. Of the people seen by a lung specialist or asthma/COPD educator ...